CREON 1236 (Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease)

Generic Name: pancrelipase

Pill with imprint CREON 1236 is Blue / Clear, Capsule-shape and has been identified as Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease. It is supplied by AbbVie, Inc..

Creon is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1236

Save up to 80% off prescription medications

Click here for your free Discount Card

Creon

Generic Name:

pancrelipase

Imprint:

CREON 1236

Strength:

180,000 units amylase / 36,000 units lipase / 114,000 units protease

Color:

Blue / Clear

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Digestive enzymes

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

AbbVie, Inc.

National Drug Code (NDC):

00032-3016

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer